%0 Journal Article
%A Jacob, Javier
%A Llauger, Lluis
%A Herrero-Puente, Pablo
%A Martín-Sánchez, Francisco Javier
%A Llorens, Pere
%A Roset, Alex
%A Gil, Victor
%A Fuentes, Marta
%A Lucas-Imbernón, Francisco Javier
%A Miró, Òscar
%A ICASEMES-Research Group
%T Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia.
%D 2019
%U http://hdl.handle.net/10668/14280
%X To study the outcomes of patients with acute heart failure (AHF) presenting renal dysfunction (RD) or hyperkalaemia (Hk) alone or in combination. We analysed the data of the EAHFE registry, a multicentre, non interventionist cohort with prospective follow-up of patients with AHF. Four groups were defined based on the presence or not of RD or Hk alone or in combination. The primary endpoint was 30-day all-cause mortality. A total of 11,935 of the 13,791 patients included in the EAHFE registry were analysed. Of these, 5088 (42.6%) did not have RD or Hk (NoRD-NoHk), 150 (1.3%) had no RD but had Hk (NoRD-Hk), 6012 (50.4%) had RD but not Hk (RD-NoHk) and 685 (5.7%) had both RD and Hk (RD-Hk). Thirty-day all-cause mortality was greatest in the RD-Hk group with an adjusted Hazard Ratio (HR) of 2.44 (confidence interval 95% [CI95%] 1.67-3.55; p  The association of 30-day all-cause mortality with the presence of RD and Hk in patients presenting AHF at admission is greater than in those without this combination.
%K Acute heart failure
%K Hyperkalaemia
%K Outcomes
%K Renal dysfunction
%~